Literature DB >> 20385961

Circulating biomarkers of collagen metabolism in cardiac diseases.

Begoña López1, Arantxa González, Javier Díez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385961     DOI: 10.1161/CIRCULATIONAHA.109.912774

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  75 in total

Review 1.  The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart.

Authors:  Shirin Doroudgar; Christopher C Glembotski
Journal:  Trends Mol Med       Date:  2011-02-01       Impact factor: 11.951

Review 2.  A reappraisal of loop diuretic choice in heart failure patients.

Authors:  Jonathan Buggey; Robert J Mentz; Bertram Pitt; Eric L Eisenstein; Kevin J Anstrom; Eric J Velazquez; Christopher M O'Connor
Journal:  Am Heart J       Date:  2015-01-06       Impact factor: 4.749

Review 3.  Circulating biomarkers in patients with heart failure and preserved ejection fraction.

Authors:  Eileen O'Meara; Simon de Denus; Jean-Lucien Rouleau; Akshay Desai
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 4.  Hypertrophy to failure: what goes wrong with the fibers of the heart?

Authors:  S K Maulik; S Mishra
Journal:  Indian Heart J       Date:  2015-03-14

5.  The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.

Authors:  Carolyn Y Ho; John J V McMurray; Allison L Cirino; Steven D Colan; Sharlene M Day; Akshay S Desai; Steven E Lipshultz; Calum A MacRae; Ling Shi; Scott D Solomon; E John Orav; Eugene Braunwald
Journal:  Am Heart J       Date:  2017-02-16       Impact factor: 4.749

Review 6.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

7.  Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Mary L Biggs; Luc Djoussé; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; Russell P Tracy; Susan J Zieman; Kenneth J Mukamal
Journal:  Am J Epidemiol       Date:  2014-04-25       Impact factor: 4.897

Review 8.  Cell- and molecular-level mechanisms contributing to diastolic dysfunction in HFpEF.

Authors:  Kenneth S Campbell; Vincent L Sorrell
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

9.  Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Luc Djousse; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; George L King; Ken J Mukamal
Journal:  Metabolism       Date:  2015-07-21       Impact factor: 8.694

Review 10.  Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

Authors:  Michael R Zile; Catalin F Baicu
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.